Equities

Fonet Bilgi Teknolojileri AS

  • Add to watchlist
  • Add to portfolio
  • Add an alert
FONET.E:IST

Fonet Bilgi Teknolojileri AS

Actions
Health CareMedical Equipment and Services
  • Price (TRY)3.40
  • Today's Change0.16 / 4.94%
  • Shares traded95.93m
  • 1 Year change+47.63%
  • Beta1.0834
Data delayed at least 15 minutes, as of Feb 13 2026 15:09 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Fonet Bilgi Teknolojileri AS is a Turkey-based company, which develops software for the healthcare sector. Its products include: FONET Software Hospital Information Management Systems (HIMS), which provides integration of required administrative, medical and financial information of public hospitals and private health institutions; FONET Laboratory Information Systems (LIS), a system management software produced in the standards of Ministry of Health which can run with integration of different systems; FONET PACS software, which allows the extraction of medical images from devices and provides access to these images through Web or from computers; FONET Hospital To Hospital (H2H), an integration system among hospitals, which provide to follow-up the online service procurement processes among hospitals and provides patient and financial information sharing in projected measures; FONET Operational Business Intelligence (OPIZ), as well as FONET Appointment Systems (AS) Features.

  • Revenue in TRY (TTM)616.25m
  • Net income in TRY165.09m
  • Incorporated2001
  • Employees504.00
  • Location
    Fonet Bilgi Teknolojileri ASKizilirmak Mahallesi1445. Sokak, No:2, B/1, CankayaANKARA TurkeyTUR
  • Phone+90 3 124385919
  • Fax+90 3 124403652
  • Websitehttps://www.fonetbt.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Modulight Oyj350.62m-239.07m2.52bn71.00--1.07--7.18-0.1172-0.11720.17271.070.1254-0.79434.78102,484.90-8.55-9.90-9.25-10.66129.94119.43-68.15-88.503.46--0.081--1.74-10.6545.65--24.38--
Svas Biosana SpA6.87bn349.56m2.58bn350.006.990.72713.930.37521.271.2724.9612.210.78352.882.55405,363.603.992.946.574.9126.1727.375.094.111.344.750.5304--1.7210.3414.6818.7910.25--
Aoti Inc2.79bn103.04m2.66bn80.0021.213.4312.960.95270.01980.01980.47010.12221.322.174.65--4.87--6.54--88.13--3.69--2.542.810.5269--32.88--78.55------
Gentian Diagnostics ASA793.23m196.69m2.69bn63.0013.902.9011.313.402.732.7311.0713.100.81811.637.832,738,365.0020.29-2.9922.99-3.3655.0644.6624.80-5.844.16--0.0094--12.5225.96525.37--22.08--
Ondine Biomedical Inc70.67m-766.50m2.85bn43.00--104.71--40.34-0.0353-0.03530.00320.00090.34470.57718.03---373.83---4,807.85--65.77---1,084.66--0.7948--0.4333--70.32---32.51------
Nanexa AB51.77m-191.18m2.97bn15.00--7.57--57.42-0.2644-0.26440.06940.48740.097224.671.54813,538.40-35.91-37.21-42.59-44.9569.5693.79-369.29-355.052.07-21.980.2165---16.9370.1167.40--21.42--
AbL Diagnostics SA282.43m24.02m2.97bn20.00123.708.2647.6310.530.02880.02880.33830.43080.4416--1.60286,763.203.763.595.345.29----8.508.202.91--0.2788---5.03--424.60------
EasyMotionSkin Tec GmbH-5.18tn-5.18tn3.03bn17.00------------------------------------------------229.95---214.79------
Fonet Bilgi Teknolojileri AS616.25m165.09m3.18bn504.0019.282.1110.615.160.17640.17640.65841.610.407420.986.791,203,616.0010.9116.4711.4818.2530.3031.6026.7936.961.53--0.01770.0033.2457.81-30.0259.2967.65--
OssDsign AB881.86m-249.58m3.30bn32.00--2.18--3.75-0.5493-0.54932.062.800.51090.36726.955,629,938.00-14.46-25.42-16.05-28.5996.2985.57-28.30-82.426.33-13.770.0044--34.5148.59-2.68--24.28--
Optomed Oyj886.14m-344.19m3.31bn111.00--2.66--3.74-0.3374-0.33740.86881.120.53632.875.07154,009.00-20.83-17.19-25.75-20.6963.6064.81-38.85-34.212.03-8.910.1014--13.675.61-21.83--5.30--
BioPorto A/S253.70m-602.29m3.34bn48.00--12.56--13.16-0.1973-0.19730.0830.07740.41322.554.69962,131.60-98.08-65.22-133.92-88.7463.9064.15-237.40-222.221.71--0.1916--17.076.36-21.15---20.56--
Meditera Tibbi Mlzm Sny Tcrt AS2.49bn-50.61m3.61bn808.00--1.3038.241.45-0.4253-0.425320.9423.280.81082.844.853,257,490.00-1.876.25-2.237.4732.7042.44-2.316.902.17--0.01180.36-0.115155.2796.6241.97----
Senzime AB (publ)439.11m-590.43m3.84bn50.00--2.25--8.75-0.8672-0.86720.63942.220.2341.735.991,794,120.00-31.47-35.09-34.04-37.5241.868.75-134.46-400.654.30-7.700.0399--63.5554.1811.50--40.12--
Agfa Gevaert NV57.28bn-3.68bn3.93bn4.74k--0.2643--0.0687-0.468-0.47966.771.850.82522.394.78233,073.20-5.15-4.74-7.10-6.8629.7729.67-6.24-6.361.172.500.3798---1.04-10.44-71.70--3.44--
Data as of Feb 13 2026. Currency figures normalised to Fonet Bilgi Teknolojileri AS's reporting currency: Turkish Lira TRY
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.